Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#1918 Case Study: Immunotherapy in a Young Adult with Atypical Neuroendocrine Tumour
Introduction: Use of immunotherapy PD-1 antibody has emerged as a novel therapeutic option for treating multiple solid tumors. In the setting of neuroendocrine tumors (NETs), little is known. Currently, trials are underway investigating its use in high-grade NETs, but outcomes remain to be seen
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Kavan P
Authors: Stavrides-Eid M, Soo Rho Y, Barrera I, Kavan P,
Keywords: thymic neuroendocrine tumour, pembrolizumab, atypical carcinoid, NETs,
Introduction: Guidelines by ENETS in the management of Gastroenteropancreatic Neuroendocrine Tumors (GP-NETS) are intended as a clinical tool to practice evidence-based medicine. Its adaptability and translation in real-life setting has yet to be examined.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Kavan P
Authors: Kavan P, Barrera I, Rho Y, Stavrides-Eid M, Gilabert M,
Keywords: neuroendocrine, tumour, guideline,
Introduction: Neuroendocrine tumors are an entity of rare, heterogeneous group of tumors that can arise from different sites within the body. Although number of different treatment types and modalities exist, chemotherapy remains as the first line option in the management of advance pancreatic NETS (pNETS); two targeted therapies, sunitinib and everolimus remains available only for second line and beyond in Canada.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Kavan P
Authors: Rho Y, Gilabert M, McLean J, Kavan P,
Keywords: targeted therapy, sunitinib, everolimus, PNET,